https://atlantak.com/fda-%eb%a0%98%eb%8d%b0%ec%8b%9c%eb%b9%84%eb%a5%b4-%ea%b2%bd%ec%a6%9d%ed%99%98%ec%9e%90%ec%97%90%eb%8f%84-%ec%b2%98%eb%b0%a9-%ed%97%88%ec%9a%a9/
FDA, 렘데시비르 경증환자에도 처방 허용